BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 9862739)

  • 1. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
    Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
    J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    Early GS; Zhao W; Burns CM
    J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
    Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
    J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resting B cells from autoimmune lupus-prone New Zealand Black and (New Zealand Black x New Zealand White)F1 mice are hyper-responsive to T cell-derived stimuli.
    Jongstra-Bilen J; Vukusic B; Boras K; Wither JE
    J Immunol; 1997 Dec; 159(12):5810-20. PubMed ID: 9550377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies in mice lacking terminal deoxynucleotidyl transferase: evidence for a role of N region addition in the polyreactivity and in the affinities of anti-DNA antibodies.
    Weller S; Conde C; Knapp AM; Levallois H; Gilfillan S; Pasquali JL; Martin T
    J Immunol; 1997 Oct; 159(8):3890-8. PubMed ID: 9378977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice.
    McCoy KL; Kendrick L; Chused TM
    J Immunol; 1986 Feb; 136(4):1217-22. PubMed ID: 3944456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 Fas(lpr) mice.
    Molano ID; Wloch MK; Alexander AA; Watanabe H; Gilkeson GS
    Clin Immunol; 2000 Jan; 94(1):24-32. PubMed ID: 10607487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
    Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
    Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
    Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A
    Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell tolerance to self antigens in New Zealand hybrid mice with lupus-like disease.
    Kotzin BL; Kappler JW; Marrack PC; Herron LR
    J Immunol; 1989 Jul; 143(1):89-94. PubMed ID: 2786535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
    Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
    J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
    Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH
    Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental abnormalities of terminal deoxynucleotidyl transferase positive bone marrow cells and thymocytes in New Zealand mice: effects of prostaglandin E1.
    Whittum J; Goldschneider I; Greiner D; Zurier R
    J Immunol; 1985 Jul; 135(1):272-80. PubMed ID: 3873491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.
    Haas C; Ryffel B; Le Hir M
    J Immunol; 1998 Apr; 160(8):3713-8. PubMed ID: 9558072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the New Zealand Black contribution to lupus-like renal disease. Multiple genes that operate in a threshold manner.
    Drake CG; Rozzo SJ; Hirschfeld HF; Smarnworawong NP; Palmer E; Kotzin BL
    J Immunol; 1995 Mar; 154(5):2441-7. PubMed ID: 7868910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells.
    Kaliyaperumal A; Michaels MA; Datta SK
    J Immunol; 1999 May; 162(10):5775-83. PubMed ID: 10229810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) mice.
    Robey IF; Peterson M; Horwitz MS; Kono DH; Stratmann T; Theofilopoulos AN; Sarvetnick N; Teyton L; Feeney AJ
    J Immunol; 2004 Apr; 172(7):4624-9. PubMed ID: 15034081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new pathogenic players in lupus: autoantibody-secreting cells are present in nephritic kidneys of (NZBxNZW)F1 mice.
    Lacotte S; Dumortier H; Décossas M; Briand JP; Muller S
    J Immunol; 2010 Apr; 184(7):3937-45. PubMed ID: 20181885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.